China Medical System Holdings Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Medical System Holdings Limited with three other
companies in this sector in China:
Northeast Pharmaceutical Group Co., Ltd.
sales of 4.81 billion Chinese Renmimbi [US$748.06 million]
of which 61%
was Pharmaceutical Products),
Hubei Jumpcan Pharmaceutical Co Ltd
(4.68 billion Chinese Renmimbi [US$727.02 million]
of which 96%
was Industrial Manufacturing), and
KPC Pharmaceuticals Inc
(5.10 billion Chinese Renmimbi [US$792.73 million]
of which 47%
was Drugs Wholesale and Retail).
During the year ended December of 2016, sales at
China Medical System Holdings Limited were 4.90 billion Chinese Renmimbi (US$761.68 million).
increase of 37.9%
versus 2015, when the company's sales were 3.55 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at China Medical System Holdings Limited
(and since 2011, sales have increased a total of 261%).